Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (7) Kammertöns, Thomas Dr. (3) Kirchner, Marieluise Dr. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Pombo, Ana Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (6) Uckert, Wolfgang Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (6) (-) Landthaler, Markus Prof. Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Biologie maligner Lymphome (6) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (1) Myologie (1) (-) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (6) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Onkologie solider Tumore (1) 2002 (1) 2003 (3) 2004 (2) 2005 (3) (-) 2006 (5) 2007 (2) 2008 (2) 2009 (3) 2010 (2) 2011 (7) (-) 2012 (3) 2013 (2) 2014 (3) 2015 (6) 2016 (4) 2017 (5) 2018 (3) 2020 (6) 2021 (7) 2023 (6) 2024 (1) 8 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Landthaler, Markus Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie Proteom Dynamik20062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas 08. Juni 2012 / Mol Cell The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts A.G. Baltz M. Munschauer B. Schwanhaeusser A. Vasile Y. Murakawa M. Schueler N. Youngs D. Penfold-Brown K. Drew M. Milek E. Wyler R. Bonneau M. Selbach C. Dieterich M. Landthaler 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. November 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky
01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
08. Juni 2012 / Mol Cell The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts A.G. Baltz M. Munschauer B. Schwanhaeusser A. Vasile Y. Murakawa M. Schueler N. Youngs D. Penfold-Brown K. Drew M. Milek E. Wyler R. Bonneau M. Selbach C. Dieterich M. Landthaler
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. November 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky